Mitochondria, cell death, and B cell tolerance.

Paula B Deming, Jeffrey C Rathmell
{"title":"Mitochondria, cell death, and B cell tolerance.","authors":"Paula B Deming,&nbsp;Jeffrey C Rathmell","doi":"10.1159/000090774","DOIUrl":null,"url":null,"abstract":"<p><p>To prevent autoimmunity, it is critical that tolerance mechanisms block autoantibody production from self-reactive B cells. B cell tolerance is maintained through mechanisms that can reversibly or irreversibly silence autoreactive B cells. Of these mechanisms, those that lead to B cell death offer the most reliable form of tolerance to prevent autoimmunity. In many cases, death of autoreactive B cells is regulated by the cell intrinsic, or mitochondrial pathway of cell death. The pro-apoptotic Bcl-2 family proteins, Bak, Bax, and Bim have been shown to be required for disruption of mitochondria and intrinsic cell death of self-reactive B cells whereas the anti-apoptotic Bcl-2, Bcl-xL, and Mcl-1 can prevent cell death by interfering with the action of Bax and Bak. Bcl-2 and Bcl-xL have also been shown to regulate the autophagic cell death pathway that may also play a role in B cell tolerance. Even after mitochondrial disruption, mechanisms exist that may impede activation of caspases and death of autoreactive B cells. Together, understanding of cell death mechanisms and how they may affect B cell tolerance has made significant recent advances and it is now important to incorporate alternate and post-mitochondrial cell death mechanisms into B cell tolerance models.</p>","PeriodicalId":81058,"journal":{"name":"Current directions in autoimmunity","volume":"9 ","pages":"95-119"},"PeriodicalIF":0.0000,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000090774","citationCount":"21","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current directions in autoimmunity","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000090774","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 21

Abstract

To prevent autoimmunity, it is critical that tolerance mechanisms block autoantibody production from self-reactive B cells. B cell tolerance is maintained through mechanisms that can reversibly or irreversibly silence autoreactive B cells. Of these mechanisms, those that lead to B cell death offer the most reliable form of tolerance to prevent autoimmunity. In many cases, death of autoreactive B cells is regulated by the cell intrinsic, or mitochondrial pathway of cell death. The pro-apoptotic Bcl-2 family proteins, Bak, Bax, and Bim have been shown to be required for disruption of mitochondria and intrinsic cell death of self-reactive B cells whereas the anti-apoptotic Bcl-2, Bcl-xL, and Mcl-1 can prevent cell death by interfering with the action of Bax and Bak. Bcl-2 and Bcl-xL have also been shown to regulate the autophagic cell death pathway that may also play a role in B cell tolerance. Even after mitochondrial disruption, mechanisms exist that may impede activation of caspases and death of autoreactive B cells. Together, understanding of cell death mechanisms and how they may affect B cell tolerance has made significant recent advances and it is now important to incorporate alternate and post-mitochondrial cell death mechanisms into B cell tolerance models.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
线粒体,细胞死亡和B细胞耐受性。
为了防止自身免疫,耐受机制阻断自身反应性B细胞产生自身抗体是至关重要的。B细胞的耐受性是通过可逆或不可逆地抑制自身反应性B细胞的机制来维持的。在这些机制中,那些导致B细胞死亡的机制提供了最可靠的耐受性形式来防止自身免疫。在许多情况下,自身反应性B细胞的死亡受细胞内在或线粒体死亡途径的调节。促凋亡的Bcl-2家族蛋白Bak、Bax和Bim已被证明是破坏线粒体和自反应性B细胞内在细胞死亡所必需的,而抗凋亡的Bcl-2、Bcl-xL和Mcl-1可以通过干扰Bax和Bak的作用来防止细胞死亡。Bcl-2和Bcl-xL也被证明调节自噬细胞死亡途径,也可能在B细胞耐受中发挥作用。即使在线粒体断裂后,存在可能阻碍半胱天冬酶激活和自身反应性B细胞死亡的机制。总之,对细胞死亡机制及其如何影响B细胞耐受性的理解最近取得了重大进展,现在重要的是将替代和线粒体后细胞死亡机制纳入B细胞耐受性模型。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Cellular mechanisms of TNF function in models of inflammation and autoimmunity. Posttranscriptional regulation of TNF mRNA: a paradigm of signal-dependent mRNA utilization and its relevance to pathology. The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions. Role of TNF in pathologies induced by nuclear factor kappaB deficiency. Type I interferon: a new player in TNF signaling.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1